Live flavivirus vaccines: reasons for caution (Q35811332)

10 August 2017

1 reference

title

Live flavivirus vaccines: reasons for caution (English)

1 reference

10 August 2017

Ernest A Gould

1 reference

10 August 2017

Stephen J Seligman

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

363

1 reference

10 August 2017

issue

9426

1 reference

10 August 2017

page(s)

2073-2075

1 reference

Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

The future of dengue vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Tick-borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Western equine encephalitis virus is a recombinant virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

The extent of homologous recombination in members of the genus Flavivirus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Emerging Infections, Transfusion Safety, and Epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Transmission of West Nile Virus through Blood Transfusion in the United States in 2002

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Transmission of West Nile virus from an organ donor to four transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Tick‐Borne Encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Development of Resistance to Acyclovir during Chronic Infection with the Oka Vaccine Strain of Varicella‐Zoster Virus, in an Immunosuppressed Child

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Rarity of adverse effects after 17D yellow-fever vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Effects of yellow fever vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Effects of yellow fever vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

Effects of yellow fever vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916459-3

7 January 2021

10.1016/S0140-6736(04)16459-3

Identifiers

DOI

1 reference

release_7sbbthfc2zfqhpp4ll3fafzv44

10 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7sbbthfc2zfqhpp4ll3fafzv44

24 November 2022

mapped directly with Wikidata item

1 reference